Detalles de la búsqueda
1.
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
Prostate
; 74(15): 1471-80, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154739
2.
Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease.
Mol Med Rep
; 24(6)2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726256
3.
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
BJU Int
; 106(2): 212-7, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20070299
4.
Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital.
Urol Int
; 83(4): 452-7, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19996654
5.
Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
Urol Int
; 82(3): 318-23, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19440021
6.
Is PSA density still useful in diagnosing prostate cancer?
Arch Ital Urol Androl
; 81(4): 199-202, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20608140
7.
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.
Clin Genitourin Cancer
; 17(4): e751-e758, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126772
8.
Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment.
J Urol
; 180(3): 886-90; discussion 891, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18635223
9.
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.
Urol Ann
; 7(1): 21-5, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25657538
10.
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma.
J Cancer Res Clin Oncol
; 129(8): 472-6, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12884023
11.
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
Urology
; 81(2): 277-81, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23374781
12.
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
Clin Genitourin Cancer
; 10(3): 174-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22502790
13.
[Prevention of topic toxicity of BCG with single-dose prulifloxacin. Preliminary results of a randomized pilot study]. / Prevenzione della tossicità topica del BCG con prulifloxacina in monodose. Risultati preliminari di uno studio pilota randomizzato.
Urologia
; 77(4): 240-7, 2010.
Artículo
en Italiano
| MEDLINE | ID: mdl-21234866
14.
Is free/total PSA predictive of pathological stage and Gleason score in patients with prostate cancer and serum PSA
Urol Int
; 76(3): 232-5, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16601385
15.
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.
Urology
; 65(1): 65-9, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15667865
16.
TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Eur Urol
; 45(6): 730-5; discussion 735-6, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15149744
Resultados
1 -
16
de 16
1
Próxima >
>>